These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32557982)

  • 21. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands.
    Fronik P; Poetsch I; Kastner A; Mendrina T; Hager S; Hohenwallner K; Schueffl H; Herndler-Brandstetter D; Koellensperger G; Rampler E; Kopecka J; Riganti C; Berger W; Keppler BK; Heffeter P; Kowol CR
    J Med Chem; 2021 Aug; 64(16):12132-12151. PubMed ID: 34403254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.
    Meehan J; Ward C; Turnbull A; Bukowski-Wills J; Finch AJ; Jarman EJ; Xintaropoulou C; Martinez-Perez C; Gray M; Pearson M; Mullen P; Supuran CT; Carta F; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2017 Jun; 8(26):42857-42875. PubMed ID: 28476026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
    Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
    Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
    Ma L; Ma R; Wang Z; Yiu SM; Zhu G
    Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyruvate dehydrogenase kinase 1 and carbonic anhydrase IX targeting in hypoxic tumors.
    Kery M; Oravcova N; Radenkovic S; Iuliano F; Tomaskova J; Golias T
    Neoplasma; 2018 Dec; 66(1):63-72. PubMed ID: 30509100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles.
    Nocentini A; Trallori E; Singh S; Lomelino CL; Bartolucci G; Di Cesare Mannelli L; Ghelardini C; McKenna R; Gratteri P; Supuran CT
    J Med Chem; 2018 Dec; 61(23):10860-10874. PubMed ID: 30433782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX.
    Dvořanová J; Kugler M; Holub J; Šícha V; Das V; Nekvinda J; El Anwar S; Havránek M; Pospíšilová K; Fábry M; Král V; Medvedíková M; Matějková S; Lišková B; Gurská S; Džubák P; Brynda J; Hajdúch M; Grüner B; Řezáčová P
    Eur J Med Chem; 2020 Aug; 200():112460. PubMed ID: 32505851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
    Gibson D
    J Inorg Biochem; 2021 Apr; 217():111353. PubMed ID: 33477089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.
    Stanica L; Gheorghiu M; Stan M; Polonschii C; David S; Bratu D; Dinischiotu A; Supuran CT; Gheorghiu E
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1079-1090. PubMed ID: 28783982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.
    van Kuijk SJ; Gieling RG; Niemans R; Lieuwes NG; Biemans R; Telfer BA; Haenen GR; Yaromina A; Lambin P; Dubois LJ; Williams KJ
    PLoS One; 2016; 11(8):e0161040. PubMed ID: 27513947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages.
    Alsaab HO; Sau S; Alzhrani RM; Cheriyan VT; Polin LA; Vaishampayan U; Rishi AK; Iyer AK
    Biomaterials; 2018 Nov; 183():280-294. PubMed ID: 30179778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.
    Zandberga E; Zayakin P; Ābols A; Pūpola D; Trapencieris P; Linē A
    Cancer Biol Ther; 2017 Aug; 18(8):596-605. PubMed ID: 28665755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions.
    Coviello V; Marchi B; Sartini S; Quattrini L; Marini AM; Simorini F; Taliani S; Salerno S; Orlandi P; Fioravanti A; Desidero TD; Vullo D; Da Settimo F; Supuran CT; Bocci G; La Motta C
    J Med Chem; 2016 Jul; 59(13):6547-52. PubMed ID: 27305384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment.
    Krasavin M; Shetnev A; Sharonova T; Baykov S; Kalinin S; Nocentini A; Sharoyko V; Poli G; Tuccinardi T; Presnukhina S; Tennikova TB; Supuran CT
    Eur J Med Chem; 2019 Feb; 164():92-105. PubMed ID: 30594030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer.
    Muhammad N; Tan CP; Nawaz U; Wang J; Wang FX; Nasreen S; Ji LN; Mao ZW
    Inorg Chem; 2020 Sep; 59(17):12632-12642. PubMed ID: 32838518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.
    Cui J; Zhang Q; Song Q; Wang H; Dmitriev P; Sun MY; Cao X; Wang Y; Guo L; Indig IH; Rosenblum JS; Ji C; Cao D; Yang K; Gilbert MR; Yao Y; Zhuang Z
    Neuro Oncol; 2019 Nov; 21(11):1436-1446. PubMed ID: 31276594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
    Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
    J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.